CEVI — CellaVision AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual balance sheet for CellaVision AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	102	130	108	122	149
Net Total Accounts Receivable
Net Total Receivables	106	114	120	110	122
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	298	365	377	366	403
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	47.4	80.3	110	126	120
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	668	825	892	929	1,013
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	104	135	133	119	109
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	238	282	250	212	197
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	430	543	642	716	816
Total Liabilities & Shareholders' Equity	668	825	892	929	1,013
Total Common Shares Outstanding